Loading clinical trials...
Loading clinical trials...
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Efficacy and Safety of 0.25% HL036 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye
Conditions
Interventions
HL036 Ophthalmic Solution
Placebo
Locations
12
United States
Cornea and Cataract Consultants of Arizona
Phoenix, Arizona, United States
Eye Research Foundation
Newport Beach, California, United States
East West Eye Institute
Torrance, California, United States
Specialty Retina Center
Boynton Beach, Florida, United States
Specialty Retina Center
Coral Springs, Florida, United States
Eye Care Centers Management Inc
Morrow, Georgia, United States
Start Date
March 10, 2019
Primary Completion Date
November 22, 2019
Completion Date
November 22, 2019
Last Updated
April 14, 2022
NCT07463950
NCT07363824
NCT07396441
NCT05865457
NCT05865379
NCT07366944
Lead Sponsor
HanAll BioPharma Co., Ltd.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions